Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.

Parks, Mary; Rosebraugh, Curtis
The New England journal of medicine; 2010 Mar 4;362(9):774-7. PMID: 20164475
Division of Metabolism and Endocrinology Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.